| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T106 |
0-339 |
Sentence |
denotes |
68 As outlined in Table 2 benefits of MSC therapy in experimental adult lung diseases include, but are not limited to, improvements in alveolar, airway, and vascular structure; attenuation of lung inflammation; decreased pulmonary fibrosis; reduced pulmonary edema, hemorrhage, and alveolar and endothelial permeability; and Abbreviations: |
| TextSentencer_T106 |
0-339 |
Sentence |
denotes |
68 As outlined in Table 2 benefits of MSC therapy in experimental adult lung diseases include, but are not limited to, improvements in alveolar, airway, and vascular structure; attenuation of lung inflammation; decreased pulmonary fibrosis; reduced pulmonary edema, hemorrhage, and alveolar and endothelial permeability; and Abbreviations: |
